Vaxart, Inc.: cash_and_equivalents
| Value | {"amount": 8405000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2016-12-31) |
| Status | current |
| Entity | Vaxart, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:09:58.901789+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/19a7c772-c54d-49cd-9e0d-1c992d680feb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001513162-18-000133 · Open the official SEC filing →Retrieved: 2026-08-19T07:09:58.901789+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000072444/cash-and-equivalents/2016-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/19a7c772-c54d-49cd-9e0d-1c992d680feb
History
- supersedes {"amount": 38100000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001437749-17-001767)